French translation and linguistic validation of the Raynaud's condition score.
Raynaud's phenomenon
Systemic scleroderma
Journal
Therapie
ISSN: 1958-5578
Titre abrégé: Therapie
Pays: France
ID NLM: 0420544
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
21
01
2019
accepted:
15
03
2019
pubmed:
27
4
2019
medline:
30
4
2020
entrez:
27
4
2019
Statut:
ppublish
Résumé
The Raynaud's condition score is a 11-point scale severity score used in Raynaud's phenomenon clinical trials since 1998. The Raynaud's condition score diary has been recommended for use in clinical trials assessing efficacy of interventions on scleroderma related Raynaud's phenomenon. However, this score has never been formally validated in French. We thus performed a translation and a linguistic validation of the Raynaud's condition score through a forward/backward translations process followed by an expert review and cognitive patient interviews. The translations led to a French version of the Raynaud's condition score that was linguistically valid, and conceptually equivalent to the original English version. This "Score de Raynaud" will be usable to perform and harmonize clinical trials in French-speaking patients with secondary Raynaud's phenomenon.
Identifiants
pubmed: 31023622
pii: S0040-5957(19)30057-5
doi: 10.1016/j.therap.2019.03.002
pii:
doi:
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
627-631Informations de copyright
Copyright © 2019 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.